These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

382 related articles for article (PubMed ID: 20639395)

  • 1. Early heart failure in the SMNDelta7 model of spinal muscular atrophy and correction by postnatal scAAV9-SMN delivery.
    Bevan AK; Hutchinson KR; Foust KD; Braun L; McGovern VL; Schmelzer L; Ward JG; Petruska JC; Lucchesi PA; Burghes AH; Kaspar BK
    Hum Mol Genet; 2010 Oct; 19(20):3895-905. PubMed ID: 20639395
    [TBL] [Abstract][Full Text] [Related]  

  • 2. AAV9-Stathmin1 gene delivery improves disease phenotype in an intermediate mouse model of spinal muscular atrophy.
    Villalón E; Kline RA; Smith CE; Lorson ZC; Osman EY; O'Day S; Murray LM; Lorson CL
    Hum Mol Genet; 2019 Nov; 28(22):3742-3754. PubMed ID: 31363739
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rescue of the spinal muscular atrophy phenotype in a mouse model by early postnatal delivery of SMN.
    Foust KD; Wang X; McGovern VL; Braun L; Bevan AK; Haidet AM; Le TT; Morales PR; Rich MM; Burghes AH; Kaspar BK
    Nat Biotechnol; 2010 Mar; 28(3):271-4. PubMed ID: 20190738
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A large animal model of spinal muscular atrophy and correction of phenotype.
    Duque SI; Arnold WD; Odermatt P; Li X; Porensky PN; Schmelzer L; Meyer K; Kolb SJ; Schümperli D; Kaspar BK; Burghes AH
    Ann Neurol; 2015 Mar; 77(3):399-414. PubMed ID: 25516063
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intravenous scAAV9 delivery of a codon-optimized SMN1 sequence rescues SMA mice.
    Dominguez E; Marais T; Chatauret N; Benkhelifa-Ziyyat S; Duque S; Ravassard P; Carcenac R; Astord S; Pereira de Moura A; Voit T; Barkats M
    Hum Mol Genet; 2011 Feb; 20(4):681-93. PubMed ID: 21118896
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Decreasing disease severity in symptomatic, Smn(-/-);SMN2(+/+), spinal muscular atrophy mice following scAAV9-SMN delivery.
    Glascock JJ; Osman EY; Wetz MJ; Krogman MM; Shababi M; Lorson CL
    Hum Gene Ther; 2012 Mar; 23(3):330-5. PubMed ID: 22029744
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Motor transmission defects with sex differences in a new mouse model of mild spinal muscular atrophy.
    Deguise MO; De Repentigny Y; Tierney A; Beauvais A; Michaud J; Chehade L; Thabet M; Paul B; Reilly A; Gagnon S; Renaud JM; Kothary R
    EBioMedicine; 2020 May; 55():102750. PubMed ID: 32339936
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Normalization of Patient-Identified Plasma Biomarkers in SMNΔ7 Mice following Postnatal SMN Restoration.
    Arnold WD; Duque S; Iyer CC; Zaworski P; McGovern VL; Taylor SJ; von Herrmann KM; Kobayashi DT; Chen KS; Kolb SJ; Paushkin SV; Burghes AH
    PLoS One; 2016; 11(12):e0167077. PubMed ID: 27907033
    [TBL] [Abstract][Full Text] [Related]  

  • 9. AAV9-Mediated Expression of SMN Restricted to Neurons Does Not Rescue the Spinal Muscular Atrophy Phenotype in Mice.
    Besse A; Astord S; Marais T; Roda M; Giroux B; Lejeune FX; Relaix F; Smeriglio P; Barkats M; Biferi MG
    Mol Ther; 2020 Aug; 28(8):1887-1901. PubMed ID: 32470325
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SMNDelta7, the major product of the centromeric survival motor neuron (SMN2) gene, extends survival in mice with spinal muscular atrophy and associates with full-length SMN.
    Le TT; Pham LT; Butchbach ME; Zhang HL; Monani UR; Coovert DD; Gavrilina TO; Xing L; Bassell GJ; Burghes AH
    Hum Mol Genet; 2005 Mar; 14(6):845-57. PubMed ID: 15703193
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SMN expression is required in motor neurons to rescue electrophysiological deficits in the SMNΔ7 mouse model of SMA.
    McGovern VL; Iyer CC; Arnold WD; Gombash SE; Zaworski PG; Blatnik AJ; Foust KD; Burghes AH
    Hum Mol Genet; 2015 Oct; 24(19):5524-41. PubMed ID: 26206889
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PTEN depletion decreases disease severity and modestly prolongs survival in a mouse model of spinal muscular atrophy.
    Little D; Valori CF; Mutsaers CA; Bennett EJ; Wyles M; Sharrack B; Shaw PJ; Gillingwater TH; Azzouz M; Ning K
    Mol Ther; 2015 Feb; 23(2):270-7. PubMed ID: 25369768
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Defining the therapeutic window in a severe animal model of spinal muscular atrophy.
    Robbins KL; Glascock JJ; Osman EY; Miller MR; Lorson CL
    Hum Mol Genet; 2014 Sep; 23(17):4559-68. PubMed ID: 24722206
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Restoration of SMN to Emx-1 expressing cortical neurons is not sufficient to provide benefit to a severe mouse model of Spinal Muscular Atrophy.
    Taylor AS; Glascock JJ; Rose FF; Lutz C; Lorson CL
    Transgenic Res; 2013 Oct; 22(5):1029-36. PubMed ID: 23512182
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Direct central nervous system delivery provides enhanced protection following vector mediated gene replacement in a severe model of spinal muscular atrophy.
    Glascock JJ; Shababi M; Wetz MJ; Krogman MM; Lorson CL
    Biochem Biophys Res Commun; 2012 Jan; 417(1):376-81. PubMed ID: 22172949
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improved therapeutic approach for spinal muscular atrophy via ubiquitination-resistant survival motor neuron variant.
    Rhee J; Kang JS; Jo YW; Yoo K; Kim YL; Hann SH; Kim YE; Kim H; Kim JH; Kong YY
    J Cachexia Sarcopenia Muscle; 2024 Aug; 15(4):1404-1417. PubMed ID: 38650097
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The human centromeric survival motor neuron gene (SMN2) rescues embryonic lethality in Smn(-/-) mice and results in a mouse with spinal muscular atrophy.
    Monani UR; Sendtner M; Coovert DD; Parsons DW; Andreassi C; Le TT; Jablonka S; Schrank B; Rossoll W; Prior TW; Morris GE; Burghes AH
    Hum Mol Genet; 2000 Feb; 9(3):333-9. PubMed ID: 10655541
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development and characterization of an SMN2-based intermediate mouse model of Spinal Muscular Atrophy.
    Cobb MS; Rose FF; Rindt H; Glascock JJ; Shababi M; Miller MR; Osman EY; Yen PF; Garcia ML; Martin BR; Wetz MJ; Mazzasette C; Feng Z; Ko CP; Lorson CL
    Hum Mol Genet; 2013 May; 22(9):1843-55. PubMed ID: 23390132
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuronal SMN expression corrects spinal muscular atrophy in severe SMA mice while muscle-specific SMN expression has no phenotypic effect.
    Gavrilina TO; McGovern VL; Workman E; Crawford TO; Gogliotti RG; DiDonato CJ; Monani UR; Morris GE; Burghes AH
    Hum Mol Genet; 2008 Apr; 17(8):1063-75. PubMed ID: 18178576
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Partial restoration of cardio-vascular defects in a rescued severe model of spinal muscular atrophy.
    Shababi M; Habibi J; Ma L; Glascock JJ; Sowers JR; Lorson CL
    J Mol Cell Cardiol; 2012 May; 52(5):1074-82. PubMed ID: 22285962
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.